outpatient-authorization-submission-mhcp.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1951 - 1960 ntawm 4179
Tus kws kho mob
P57-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P58-23 Medicare Advantage Part B Step Therapy Program Expansion to Include Vyvgart and Ultomiris
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2023
Tus kws kho mob
2023 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2023
Tus kws kho mob
QP65-23 New Medical Coding Pattern Education Program
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 26, 2023
Tus kws kho mob
QP60-23 Commercial Pharmacy Benefit Exclusion for Elfabrio®, Vyjuvek™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tus kws kho mob
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tus kws kho mob
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tus kws kho mob
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tus kws kho mob
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023